A DIFFERENT APPROACH TO HYPERTENSION
The Medtronic Renal Denervation (RDN) procedure (also known as the Blood Pressure Procedure) delivers energy to the nerves leading to the kidneys that help regulate blood pressure. This minimally invasive method may help achieve a sustained reduction in blood pressure. RDN also offers the opportunity to reduce blood pressure, independent of patient medication adherence.1
RDN Overview
Basics of high blood pressure and how RDN may be an option for some patients
Maggiori informazioni
Less information (see less)
A PROCEDURE, NOT A PILL
Renal denervation offers a different way to improve your patients’ hypertension that works with lifestyle changes, and is not dependent on medication adherence.
- A procedure, not a daily pill
- Complementary to existing therapies
- Results are independent of current drug regimen1,2
- Works independently of patient adherence, 24-hours a day1
KIDNEYS ARE KEY
Kidneys are part of the body's blood pressure control mechanism. Overactivity of the nerves that travel to the kidneys can cause high blood pressure.3 These nerves can be down-regulated to help the kidneys better manage blood pressure.4
The Symplicity Spyral™ multi-electrode renal denervation catheter achieving 360-degree ablation in the renal artery leading to the kidney.
THE MEDTRONIC RENAL DENERVATION PROCEDURE
In the Medtronic RDN procedure, the Symplicity Spyral™ catheter is positioned in the renal arteries. Under the control of the radiofrequency generator, energy is delivered to ablate the surrounding nerves 360 degrees, to help control blood pressure.
RDN Symplicity SPYRAL Animation
A video showing the RDN Symplicity SPYRAL Animation.
Maggiori informazioni
Less information (see less)
STEP 1:
An interventional catheter (described to patients as a thin tube) is inserted into the renal arteries leading to the kidney.
STEP 2:
That catheter is kept in place for one minute at a time, delivering energy to help regulate the nerves.
STEP 3:
Typically, the interventional physician will decide to treat multiple portions of the renal artery.
STEP 4:
The procedure is performed in both kidneys.
STEP 5:
Following treatment, the catheter is removed and no permanent implant is left behind.
PROVEN BENEFITS
Renal denervation has been studied in more than 30 clinical trials.
The development of the Symplicity™ renal denervation device and the Symplicity Spyral™ catheter are the culmination of 12 years of rigorous scientific development.1
- Applied in more than 10,000 real-world cases2,5
- Most patients experience lower blood pressure1,2
- Medtronic RDN technology offers more than 11,000 patient years of patient follow-up6
- No major adverse events were reported through six months1,2,7
Together, we can tackle a major unmet need in hypertension.
1
Kandzari DE, et al. Lancet. 2018;391:2346–2355.
2
Townsend RR, et al. Lancet. 2017;390:2160–2170.
3
Black, HR, Elliott WJ. Hypertension: A Companion to Braunwald's Heart Disease, 2nd ed.
4
Schlaich MP et al., Journal of Hypertension. 2009; 54: 1195-1201.
5
Sales data, Medtronic data on file.
6
Medtronic data on file.
7
Medtronic safety data on file.
All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan or France.